Remote Funded Healthcare Sector Momentum Trader — Boston, MA
Boston, MA
Maverick Trading
Healthcare-sector specialist book — biotech catalysts, pharma majors, devices, payers.
Third-largest US asset-management center, ET-aligned with the NYSE, and one of the deepest professional trader communities in the country.
A healthcare sector momentum trader at Maverick focuses on US healthcare equities — biotech catalysts, large pharma, medical devices, and the managed-care payer complex. The sector spans both highly volatile catalyst-driven small-caps and defensive large-cap names, which means a healthcare specialist runs two very different sub-strategies under one umbrella.
Trading from Boston, MA
Boston is the third-largest asset-management center in the US — Fidelity, State Street, MFS, Wellington, and Putnam are all headquartered here, and the mutual-fund industry as a category was largely invented in the city. Eastern Time alignment with the NYSE is clean, and the academic ecosystem (Harvard, MIT, Boston University) feeds the local quant-trader labor market.
Local ecosystem: Fidelity HQ, State Street HQ, Wellington, MFS, Putnam; Harvard, MIT, BU.
Time zone: ET — the NYSE opens at 9:30am local for traders based in Boston.
What You'll Trade
Large pharma (JNJ, MRK, PFE, LLY) for stable trend trades and option liquidity, large biotech (AMGN, GILD, REGN) for fundamental-driven positioning, mid-cap biotech for catalyst trades around clinical data and FDA decisions, medical device names (ISRG, MDT) for steady momentum, and payers (UNH, ELV) for policy-driven moves.
Day-to-Day
- Morning: review the FDA calendar, clinical readout schedule, and overnight political/policy news affecting payers
- Track relative strength of healthcare sub-sectors versus XLV and the broader market
- Position into and out of catalyst events with defined risk — biotech binary events require options structures, not naked equity
- Manage steady-trend positions in large-caps with trailing stops
Risk Profile
Healthcare carries binary catalyst risk in biotech (one FDA decision moves a stock 40%), regulatory and political risk in payers and large pharma, and patent-cliff timing risk. Maverick limits biotech catalyst exposure to defined-risk structures and caps total sector concentration.
Who Succeeds in This Role
- Traders with a science or medical background — or who have done the work to understand it
- People who can read a clinical trial press release and assess the actual signal
- Candidates who already follow the FDA PDUFA calendar and major medical conferences
- Traders who can size catalyst trades for binary outcomes, not normal-distribution outcomes
Why This Role Exists at Maverick
Healthcare rewards domain expertise more than almost any other sector — the difference between a real clinical signal and noise isn't visible from price action alone. Maverick funds specialists who bring genuine sector knowledge, not generalists picking up healthcare names off a momentum screen.
What Maverick Offers
- Trade firm capital — no personal capital at risk
- 65%–90% profit split based on performance tier
- Performance-based capital scaling, no upper cap
- Professional training and mentorship from active traders
- Fully remote — trade from anywhere with reliable internet (US applicants)
- Monthly ACH payouts
- No challenge accounts, no evaluations, no monthly fees
About Maverick Trading
Maverick Trading is a proprietary trading firm founded in 1997. We allocate firm capital to disciplined traders and scale buying power based on performance. We are not a brokerage, we do not run challenge accounts, and we do not sell evaluations. We profit only when our traders profit.